Global Algae Market Overview

Global Algae Market was valued at USD 2.98 billion in 2021 and is expected to reach USD 3.76 billion by the year 2028, at a CAGR of 3.36%.

Algae are the diverse group of marine species that have the ability to conduct photosynthesis. Most of the people are familiar with such algae, such as pond cultivation, fermentation, seaweeds, pond scum, or lake algal blooms. The products derived from algae find applications in many sectors, including food & beverage, feed, nutraceutical, personal care, and pharmaceutical. For these various algae manufacturers are highly focusing on omega-3 fatty acid. By considering that in today’s world manufacturers are not only focusing on advertisement but also educating in the form of pamphlets and booklets to stores and parents, that algae products are in the growing process, the importance of calcium level and blood pressure. In addition, direct algae intake as a food commodity makes it a safe natural food with high nutritional value, which is a requirement for the increasing population which could also be considered as a driver for the algae products industry. These are the parameters that highly boost the sale of the algae products in future. An increase in consumer awareness regarding the selection of algae is a major reason which driving sales of the products.

Market Dynamics And Key Factors For Algae Market

Drivers:

Growing Application in Pharmaceuticals Industry

Algae-products such as carrageenan are employed as a new extrusion aid in the manufacturing of pellet polymers, as a matrix in oral extended-release tablets, and as a stabilizer in micro or nanoparticle systems. It's employed as a gelling agent and viscosity improver for controlled medication release and longer retention thanks to carrageenan's unique properties like gelling and high negative charge. Furthermore, sodium alginate, which is derived from brown seaweed, is employed in medicinal formulations as a gel. With their vast product portfolio, key competitors such as DSM are catering to the growing demand for algal products. Omega-3 is the most investigated nutrition in the world, according to the Global Organization for EPA and DHA (GOED), with over 8,000 clinical trials done in the previous decade. In the market, omega – 3 is mostly known as an algae-based product. The expansion of the algae products market has been pushed by rising healthcare expenditures throughout the world, as well as increased prevalence and consumer awareness of omega-3 for preventative healthcare.

Algae in cosmetics

Algae has been utilized in skin-care products by the natural cosmetics industry for years. Algae have developed unique sun blockers and other agents to protect and cure themselves of the harmful effects of exposure to solar radiation and other environmental threats. These substances are currently being developed into products that provide similar advantages to people, such as skin whitening and anti-wrinkling, algae against skin aging, algae as a moisturizing agent, algae as a thickening agent, algae as a skin sensitizer, algae as antioxidants, and others.

In addition, the need for algae in the plastic sector, which is used to make biodegradable plastic, is fueling market expansion. Over the forecast period, increasing use of algae in different applications such as food & drinks, pharmaceutical, nutraceutical, cosmetics, fertilizer, and others are expected to drive demand for algae.

Restraints:

Algae in Drinking Water Has a Detrimental Effect

Algae's influence on safe drinking water is complicated. Some algae species pose a threat to human and animal water systems by creating toxins that can have unpleasant, if not fatal, health consequences. Although many varieties of algae are plants or plant-like creatures, blue-green algae are cyanobacteria, a type of bacterium. Blue-green algae are photosynthetic unicellular organisms that can live in both fresh and saltwater, as well as moist soil and rocks. Algae like these may be found practically anywhere on the planet. These tiny creatures can 'bloom' on the water's surface. Blue-green algal blooms, which are most frequent during the hot summer months, can put drinking water sources at risk by releasing toxins. These poisons can cause disease and even death if consumed.

Swimming in (or drinking water from) bodies of water with blue-green algae can cause symptoms ranging from liver damage to paralysis in humans and animals. The types and quantities of cyanotoxins generated vary depending on the cyanobacteria species and the magnitude of the bloom. Ingested cyanotoxins can cause gastrointestinal discomfort, vomiting, diarrhea, irritated and bleeding liver, pneumonia, or renal damage, and may even stimulate tumor growth. Another class of cyanotoxins targets the neurological system, causing tingling, numbness, burning, sleepiness, incoherence, paralysis, and death. Contact with cyanotoxins on the skin, eyes, throat, nose, or respiratory tract can irritate. Thus, these factors are anticipated to hinder the algae market during the forecast period.

Challenges:

Choice of Algal Strains for Algal Biofuels

Natural microalgal assemblies are typically time-consuming and arduous to select, isolate, purify, and identify. The media and cultural circumstances for enhanced microalgal proliferation must be tailored to the species of interest. Both physical and genetic characteristics are frequently used in species identification. Taking notes on the sample site's environmental characteristics is critical for optimizing in vitro research. The isolated microalgal strain is then cultivated for biomass and lipid production in upscale systems. One solution is to return the creatures to their natural environments with sufficient inoculum. Furthermore, algae that thrive in the lab may not survive in the wild, particularly bio-engineered algae, which are more susceptible to viruses and predators.

Opportunities:

Extraction and manufacturing of algae need high-priced equipment and processes. The government and firms are projected to make significant expenditures in R&D to improve manufacturing processes and lower costs, which will provide a huge opportunity for the industry. For instance, by employing algal strains that do not need to be kept in the photobioreactor for an extended period, production expenses can be reduced. It is possible to build an effective and inexpensive liner for open ponds. Paddlewheel design can be improved, or other mixing procedures that are less expensive can be devised. More metabolic pathway research has been done to correlate fertilizer input with nitrogen deficit to maximize lipid content and production. For algal biomass separation, sophisticated energy-efficient methods such as electromagnetic fields or solvent extraction are available. Solar drying is another option that might help you save money on electricity. Algae drying might be accomplished using solar water heating or direct sun irradiation.

Market Segmentation

Segmentation Analysis of Algae Market:

By Type, Open pond systems are the most common system of algae cultivation, already used commercially in the United States to produce nutritional products and treat wastewater. Open pond systems use shallow (typically one-foot deep) ponds, from about one acre to several acres in size, in which the algae are exposed to natural solar radiation (sunlight) which they convert into biomass.  Microalgal production in raceway ponds seems to be most promising, especially in the large scale. Several environmental (location of the cultivation system, rainfall, solar radiation, etc.), engineering (pond depth, CO2 delivery system, methods of mixing, power consumption, etc.), and biological (light, pH, oxygen accumulation, salinity, Algal predators etc.) parameters affect the biomass productivity in the open pond system. Closed bioreactors have mainly been considered too expensive. Photo-bioreactor (PBR) can be used for microalgae cultivation against changeable outside weather conditions and insufficient land availability. The internal environmental conditions can be controlled artificially in PBRs.

By Application, Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are essential for humans, as well as for marine fish species. Fish oil is currently the main source of these fatty acids. Docosahexaenoic acid (DHA) defines Omega-3 and other PUFAs for pharmaceutical applications. It has extensive experience handling and purifying omega-3 from various biomass sources including fish oil, algae, etc. Bioplastics are plastic materials produced from renewable biomass sources, such as vegetable fats and oils, corn starch, straw, woodchips, sawdust, recycled food waste, etc. Docosapentaenoic acid (DPA), The human body has the capacity to synthesize a variety of saturated and unsaturated fatty acids, but cannot synthesize some polyunsaturated fatty acids (PUFAs), such as omega-3 and omega-6 fatty acids, due to the lack of certain elongases.

Regional Analysis of Algae Market:

North America is expected to dominate the algae products market During the forecast period, owing to the growing nutraceutical market in the United States, which is attributed to a variety of factors including an aging population, increased healthcare awareness, a higher incidence of allergies, and intolerance, and rising demand from emerging economies. Furthermore, rising health concerns and awareness, as well as changing lifestyles, are having a significant impact on all sectors of the food, cosmetics, and personal care industries, resulting in increased demand for functional food and beverages, as well as personal care products enriched with functional ingredients and active constituents, which is propelling the North American algae products market forward.

The EU Bioeconomy Strategy intends to help the EU's bio-based industries expand and develop sustainably while also producing employment, innovation, and services. The majority of seaweed enterprises in the region focus their biomass production on food (36%) and food-related applications (15%), such as food supplements, nutraceuticals, and hydrocolloid synthesis, as well as feed (10%), accounting for 61 percent of total uses. According to the outcomes of this research, there are 225 enterprises producing macroalgae (67%) and microalgae (33%) in the European algae industry. In addition, 222 Spirulina producers were found across 23 nations, 15% of them are also microalgae producers (and so included in the microalgae accounting). The countries with the most macro- and microalgae firms are Spain, France, and Ireland, followed by Norway, the United Kingdom, Germany, and Portugal. Norway, France, and Ireland are the countries in Europe that generate the most seaweed biomass.

China is expected to have positive growth prospects in the Asia Pacific region in the future, a result of rising awareness of health and wellness among the urban population and rising disposable income. In this region, pharmaceutical medications containing algae constituents such as omega 3 and protein are in great demand, prompting manufacturers to use higher amounts of algal protein in their final products. Furthermore, due to China's dominance in terms of production and export in the area, the country wielded undue control over the product market.

Players Covered in Algae Market are:

• Algae Tec
• Pond Biofuels Incorporated
• LiveFuels
• Algae Systems
• SAPPHIRE ENERGY
• SOLAZYME
• Diversified Energy Corporation
• Algenol
• KAI BIOENERGY
• Algix
• DSM Nutritional Products
• Dao Energy
• Phycal
• Kent BioEnergy Corporation and other major players.

Covid-19 Impact Analysis of Algae Market

It has been observed that the new algae-based respirator may help people wearing masks breathe easy as it’s conduct photosynthesis and remove carbon dioxide (C02) and other air pollutants while producing oxygen, making the air passing through it more breathable.
The COVID-19 outbreak has created multiple challenges in the food &beverages industry. However, marine red algae may hold the key to prevent the spread of coronavirus as biocompatible compounds extracted from them can be used as a coating material on sanitary items. Canadian researchers use algae to develop serological test kits for COVID-19 that are low-cost. It helps determining the novel coronavirus infection in a suspect. COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period.

Recent Industry Developments In Algae Market

• January 2021, Corbion to Expand Lactic Acid Capacity in North America. It will increase its capacity for producing lactic acid in North America by around 40% to meet the growing demand for natural ingredients in multiple industries.
• October 2020, Cyanotech Corporation Launches BioAstin Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, announces its launch of BioAstin Hawaiian Astaxanthin in a new delivery form, water dispersible powder, available in both 1% and 2% concentrations.
• May 2020, DSM boosts maternal and infant nutrition portfolio with new plant-based high potency DHA oil.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Algae Market by Type
 5.1 Algae Market Overview Snapshot and Growth Engine
 5.2 Algae Market Overview
 5.3 Open Ponds Cultivation
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Open Ponds Cultivation: Grographic Segmentation
 5.4 Raceway Ponds Cultivation
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Raceway Ponds Cultivation: Grographic Segmentation
 5.5 Closed Photo bioreactor Cultivation
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Closed Photo bioreactor Cultivation: Grographic Segmentation
 5.6 Closed Fermenter Systems Cultivation
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Closed Fermenter Systems Cultivation: Grographic Segmentation

Chapter 6: Algae Market by Application
 6.1 Algae Market Overview Snapshot and Growth Engine
 6.2 Algae Market Overview
 6.3 DHA Production (Protein Sales)
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 DHA Production (Protein Sales): Grographic Segmentation
 6.4 DHA Production (Pharmaceutical Applications)
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 DHA Production (Pharmaceutical Applications): Grographic Segmentation
 6.5 Bioplastics
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Bioplastics: Grographic Segmentation
 6.6 Others
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Others: Grographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 Algae Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Ansoff Matrix
  7.1.5 Algae Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 Algae Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 ALGAE TEC
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 POND BIOFUELS INCORPORATED
 7.4 LIVEFUELS
 7.5 ALGAE SYSTEMS
 7.6 SAPPHIRE ENERGY
 7.7 SOLAZYME
 7.8 DIVERSIFIED ENERGY CORPORATION
 7.9 ALGENOL
 7.10 KAI BIOENERGY
 7.11 ALGIX
 7.12 DSM NUTRITIONAL PRODUCTS
 7.13 DAO ENERGY
 7.14 PHYCAL
 7.15 KENT BIOENERGY CORPORATION
 7.16 OTHER MAJOR PLAYERS

Chapter 8: Global Algae Market Analysis, Insights and Forecast, 2016-2028
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Type
  8.2.1 Open Ponds Cultivation
  8.2.2 Raceway Ponds Cultivation
  8.2.3 Closed Photo bioreactor Cultivation
  8.2.4 Closed Fermenter Systems Cultivation
 8.3 Historic and Forecasted Market Size By Application
  8.3.1 DHA Production (Protein Sales)
  8.3.2 DHA Production (Pharmaceutical Applications)
  8.3.3 Bioplastics
  8.3.4 Others

Chapter 9: North America Algae Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 Open Ponds Cultivation
  9.4.2 Raceway Ponds Cultivation
  9.4.3 Closed Photo bioreactor Cultivation
  9.4.4 Closed Fermenter Systems Cultivation
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 DHA Production (Protein Sales)
  9.5.2 DHA Production (Pharmaceutical Applications)
  9.5.3 Bioplastics
  9.5.4 Others
 9.6 Historic and Forecast Market Size by Country
  9.6.1 U.S.
  9.6.2 Canada
  9.6.3 Mexico

Chapter 10: Europe Algae Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Open Ponds Cultivation
  10.4.2 Raceway Ponds Cultivation
  10.4.3 Closed Photo bioreactor Cultivation
  10.4.4 Closed Fermenter Systems Cultivation
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 DHA Production (Protein Sales)
  10.5.2 DHA Production (Pharmaceutical Applications)
  10.5.3 Bioplastics
  10.5.4 Others
 10.6 Historic and Forecast Market Size by Country
  10.6.1 Germany
  10.6.2 U.K.
  10.6.3 France
  10.6.4 Italy
  10.6.5 Russia
  10.6.6 Spain
  10.6.7 Rest of Europe

Chapter 11: Asia-Pacific Algae Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Open Ponds Cultivation
  11.4.2 Raceway Ponds Cultivation
  11.4.3 Closed Photo bioreactor Cultivation
  11.4.4 Closed Fermenter Systems Cultivation
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 DHA Production (Protein Sales)
  11.5.2 DHA Production (Pharmaceutical Applications)
  11.5.3 Bioplastics
  11.5.4 Others
 11.6 Historic and Forecast Market Size by Country
  11.6.1 China
  11.6.2 India
  11.6.3 Japan
  11.6.4 Singapore
  11.6.5 Australia
  11.6.6 New Zealand
  11.6.7 Rest of APAC

Chapter 12: Middle East & Africa Algae Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Open Ponds Cultivation
  12.4.2 Raceway Ponds Cultivation
  12.4.3 Closed Photo bioreactor Cultivation
  12.4.4 Closed Fermenter Systems Cultivation
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 DHA Production (Protein Sales)
  12.5.2 DHA Production (Pharmaceutical Applications)
  12.5.3 Bioplastics
  12.5.4 Others
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Turkey
  12.6.2 Saudi Arabia
  12.6.3 Iran
  12.6.4 UAE
  12.6.5 Africa
  12.6.6 Rest of MEA

Chapter 13: South America Algae Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Open Ponds Cultivation
  13.4.2 Raceway Ponds Cultivation
  13.4.3 Closed Photo bioreactor Cultivation
  13.4.4 Closed Fermenter Systems Cultivation
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 DHA Production (Protein Sales)
  13.5.2 DHA Production (Pharmaceutical Applications)
  13.5.3 Bioplastics
  13.5.4 Others
 13.6 Historic and Forecast Market Size by Country
  13.6.1 Brazil
  13.6.2 Argentina
  13.6.3 Rest of SA

Chapter 14 Investment Analysis

Chapter 15 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ALGAE MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ALGAE MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ALGAE MARKET COMPETITIVE RIVALRY
TABLE 005. ALGAE MARKET THREAT OF NEW ENTRANTS
TABLE 006. ALGAE MARKET THREAT OF SUBSTITUTES
TABLE 007. ALGAE MARKET BY TYPE
TABLE 008. OPEN PONDS CULTIVATION MARKET OVERVIEW (2016-2028)
TABLE 009. RACEWAY PONDS CULTIVATION MARKET OVERVIEW (2016-2028)
TABLE 010. CLOSED PHOTO BIOREACTOR CULTIVATION MARKET OVERVIEW (2016-2028)
TABLE 011. CLOSED FERMENTER SYSTEMS CULTIVATION MARKET OVERVIEW (2016-2028)
TABLE 012. ALGAE MARKET BY APPLICATION
TABLE 013. DHA PRODUCTION (PROTEIN SALES) MARKET OVERVIEW (2016-2028)
TABLE 014. DHA PRODUCTION (PHARMACEUTICAL APPLICATIONS) MARKET OVERVIEW (2016-2028)
TABLE 015. BIOPLASTICS MARKET OVERVIEW (2016-2028)
TABLE 016. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 017. NORTH AMERICA ALGAE MARKET, BY TYPE (2016-2028)
TABLE 018. NORTH AMERICA ALGAE MARKET, BY APPLICATION (2016-2028)
TABLE 019. N ALGAE MARKET, BY COUNTRY (2016-2028)
TABLE 020. EUROPE ALGAE MARKET, BY TYPE (2016-2028)
TABLE 021. EUROPE ALGAE MARKET, BY APPLICATION (2016-2028)
TABLE 022. ALGAE MARKET, BY COUNTRY (2016-2028)
TABLE 023. ASIA PACIFIC ALGAE MARKET, BY TYPE (2016-2028)
TABLE 024. ASIA PACIFIC ALGAE MARKET, BY APPLICATION (2016-2028)
TABLE 025. ALGAE MARKET, BY COUNTRY (2016-2028)
TABLE 026. MIDDLE EAST & AFRICA ALGAE MARKET, BY TYPE (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA ALGAE MARKET, BY APPLICATION (2016-2028)
TABLE 028. ALGAE MARKET, BY COUNTRY (2016-2028)
TABLE 029. SOUTH AMERICA ALGAE MARKET, BY TYPE (2016-2028)
TABLE 030. SOUTH AMERICA ALGAE MARKET, BY APPLICATION (2016-2028)
TABLE 031. ALGAE MARKET, BY COUNTRY (2016-2028)
TABLE 032. ALGAE TEC: SNAPSHOT
TABLE 033. ALGAE TEC: BUSINESS PERFORMANCE
TABLE 034. ALGAE TEC: PRODUCT PORTFOLIO
TABLE 035. ALGAE TEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. POND BIOFUELS INCORPORATED: SNAPSHOT
TABLE 036. POND BIOFUELS INCORPORATED: BUSINESS PERFORMANCE
TABLE 037. POND BIOFUELS INCORPORATED: PRODUCT PORTFOLIO
TABLE 038. POND BIOFUELS INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. LIVEFUELS: SNAPSHOT
TABLE 039. LIVEFUELS: BUSINESS PERFORMANCE
TABLE 040. LIVEFUELS: PRODUCT PORTFOLIO
TABLE 041. LIVEFUELS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. ALGAE SYSTEMS: SNAPSHOT
TABLE 042. ALGAE SYSTEMS: BUSINESS PERFORMANCE
TABLE 043. ALGAE SYSTEMS: PRODUCT PORTFOLIO
TABLE 044. ALGAE SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. SAPPHIRE ENERGY: SNAPSHOT
TABLE 045. SAPPHIRE ENERGY: BUSINESS PERFORMANCE
TABLE 046. SAPPHIRE ENERGY: PRODUCT PORTFOLIO
TABLE 047. SAPPHIRE ENERGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. SOLAZYME: SNAPSHOT
TABLE 048. SOLAZYME: BUSINESS PERFORMANCE
TABLE 049. SOLAZYME: PRODUCT PORTFOLIO
TABLE 050. SOLAZYME: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. DIVERSIFIED ENERGY CORPORATION: SNAPSHOT
TABLE 051. DIVERSIFIED ENERGY CORPORATION: BUSINESS PERFORMANCE
TABLE 052. DIVERSIFIED ENERGY CORPORATION: PRODUCT PORTFOLIO
TABLE 053. DIVERSIFIED ENERGY CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. ALGENOL: SNAPSHOT
TABLE 054. ALGENOL: BUSINESS PERFORMANCE
TABLE 055. ALGENOL: PRODUCT PORTFOLIO
TABLE 056. ALGENOL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. KAI BIOENERGY: SNAPSHOT
TABLE 057. KAI BIOENERGY: BUSINESS PERFORMANCE
TABLE 058. KAI BIOENERGY: PRODUCT PORTFOLIO
TABLE 059. KAI BIOENERGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. ALGIX: SNAPSHOT
TABLE 060. ALGIX: BUSINESS PERFORMANCE
TABLE 061. ALGIX: PRODUCT PORTFOLIO
TABLE 062. ALGIX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. DSM NUTRITIONAL PRODUCTS: SNAPSHOT
TABLE 063. DSM NUTRITIONAL PRODUCTS: BUSINESS PERFORMANCE
TABLE 064. DSM NUTRITIONAL PRODUCTS: PRODUCT PORTFOLIO
TABLE 065. DSM NUTRITIONAL PRODUCTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. DAO ENERGY: SNAPSHOT
TABLE 066. DAO ENERGY: BUSINESS PERFORMANCE
TABLE 067. DAO ENERGY: PRODUCT PORTFOLIO
TABLE 068. DAO ENERGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. PHYCAL: SNAPSHOT
TABLE 069. PHYCAL: BUSINESS PERFORMANCE
TABLE 070. PHYCAL: PRODUCT PORTFOLIO
TABLE 071. PHYCAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. KENT BIOENERGY CORPORATION: SNAPSHOT
TABLE 072. KENT BIOENERGY CORPORATION: BUSINESS PERFORMANCE
TABLE 073. KENT BIOENERGY CORPORATION: PRODUCT PORTFOLIO
TABLE 074. KENT BIOENERGY CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 075. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 076. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 077. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ALGAE MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ALGAE MARKET OVERVIEW BY TYPE
FIGURE 012. OPEN PONDS CULTIVATION MARKET OVERVIEW (2016-2028)
FIGURE 013. RACEWAY PONDS CULTIVATION MARKET OVERVIEW (2016-2028)
FIGURE 014. CLOSED PHOTO BIOREACTOR CULTIVATION MARKET OVERVIEW (2016-2028)
FIGURE 015. CLOSED FERMENTER SYSTEMS CULTIVATION MARKET OVERVIEW (2016-2028)
FIGURE 016. ALGAE MARKET OVERVIEW BY APPLICATION
FIGURE 017. DHA PRODUCTION (PROTEIN SALES) MARKET OVERVIEW (2016-2028)
FIGURE 018. DHA PRODUCTION (PHARMACEUTICAL APPLICATIONS) MARKET OVERVIEW (2016-2028)
FIGURE 019. BIOPLASTICS MARKET OVERVIEW (2016-2028)
FIGURE 020. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 021. NORTH AMERICA ALGAE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. EUROPE ALGAE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. ASIA PACIFIC ALGAE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. MIDDLE EAST & AFRICA ALGAE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. SOUTH AMERICA ALGAE MARKET OVERVIEW BY COUNTRY (2016-2028)